Logo image
New variant of varicella-zoster virus
Journal article   Open access   Peer reviewed

New variant of varicella-zoster virus

Graham A Tipples, Gwen M Stephens, Chris Sherlock, Margrit Bowler, Benny Hoy, Darrel Cook and Charles Grose
Emerging infectious diseases, Vol.8(12), pp.1504-1505
12/2002
DOI: 10.3201/eid0812.020118
PMCID: PMC2738511
PMID: 12498673
url
https://doi.org/10.3201/eid0812.020118View
Published (Version of record) Open Access

Abstract

In 1998, a varicella-zoster virus glycoprotein E (gE) mutant virus (VZV-MSP) was isolated from a child with chickenpox. VZV-MSP, representing a second VZV serotype, was considered a rarity. We isolated another VZV-MSP-like virus from an elderly man with herpes zoster. These gE mutant viruses may have arisen through independent mutation or may represent a distinct VZV subpopulation that emerged more than 50 years ago.
Genome, Viral Antiviral Agents - therapeutic use Herpesvirus 3, Human - classification Humans 2-Aminopurine - therapeutic use Male Herpesvirus 3, Human - genetics Herpes Zoster - drug therapy 2-Aminopurine - analogs & derivatives Polymerase Chain Reaction Herpes Zoster - physiopathology Herpesvirus 3, Human - pathogenicity Aged Child Serotyping

Details

Metrics

Logo image